STK-002

N/A

Report date: 2026/02/13 15:22:56
NME

Base Information

Drug NameSTK-002
Drug Alias NameSTK-002
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRNA interferenceOptic atrophy protein 1 modulators
TargetsOptic atrophy protein 1
Therapy Area/IndicationsOptic Atrophy, Autosomal Dominant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesStoke Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesStoke Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOptic Atrophy, Autosomal Dominant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A